Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +17819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Delequamine | C18H26N2O3S | 119905-05-4 | Details |
| 7-Methoxy-1-naphthylacetonitrile | C13H11NO | 138113-08-3 | Details |
| Anabasine | C10H14N2 | 494-52-0 | Details |
| BMS-561392 Formic acid | Details |
| (R)-PF-04822163 | Details |
| 2-Methylpyrazine | C5H6N2 | 109-08-0 | Details |
| AC 7739 | C18H21NO4.ClH | 162705-22-8 | Details |
| 9(Z)-Pentacosene | C25H50 | 51865-00-0 | Details |
| TGFβ-IN-5 | C20H16N4 | 259870-32-1 | Details |
| Rotigotine | C19H25NOS | 92206-54-7 | Details |
| DSS30 | C16H14ClNO3S2 | 883027-32-5 | Details |
| Desertomycin A | C61H109NO21 | 121820-50-6 | Details |
| RS 0481 | C19H20N2O2S | 126769-16-2 | Details |
| Ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate | C12H10ClNO3 | 99429-64-8 | Details |
| LX-4211 intermediate | C12H19NO6 | 1103738-19-7 | Details |
| Linearmycin A | C64H101NO16 | 163596-98-3 | Details |
| SKLB 1028 | C24H29N9 | 1350544-93-2 | Details |
| Antitumor agent-152 | C17H19N5O2S2 | 1209784-87-1 | Details |
| 8-CPT-Cyclic AMP (sodium salt) | C16H14ClN5NaO6PS | 93882-12-3 | Details |
| Naratriptan | C17H25N3O2S | 121679-13-8 | Details |
| 4-Methylumbelliferyl β-D-Galactopyranoside-6-sulfate (sodium salt) | C16H17NaO11S | 206443-06-3 | Details |
| (±)8(9)-DiHET | C20H34O4 | 192461-96-4 | Details |
| Anti-inflammatory agent 36 | C25H27NO7 | 2293951-01-4 | Details |
| EJMC-1 | C17H11ClN2O4S | 397281-20-8 | Details |
| Adropin (34-76) (human, mouse, rat) | 1802086-30-1 | Details |
| β-Aminoarteether | C17H29NO5 | 133162-24-0 | Details |
| VPC-18005 | C15H17N3O3S | 2242480-48-2 | Details |
| BTM-3528 | C24H19F4N3O2S2 | 2054998-45-5 | Details |
| ERCC1-XPF-IN-2 | C15H13Cl2NO3 | 1808986-37-9 | Details |
| GLP-1(28-36)amide acetate | Details |
| Locustatachykinin I acetate | Details |
| Bellidifolin | C14H10O6 | 2798-25-6 | Details |
| Demethylwedelolactone | C15H8O7 | 6468-55-9 | Details |
| SAHA-BPyne | C27H31N3O5 | 930772-88-6 | Details |
| Thioquinapiperifil dihydrochloride | C24H30Cl2N6OS | 204077-66-7 | Details |
| Cucurbitacin E | C32H44O8 | 18444-66-1 | Details |
| CAY10722 | C21H14Cl2N2O2 | 388086-13-3 | Details |
| Z-LEHD-fmk | C32H43FN6O10 | 210345-04-3 | Details |
| Vamifeport | C21H21FN6O2 | 2095668-10-1 | Details |
| cis-Parinaric Acid | C18H28O2 | 18427-44-6 | Details |
| Xanomeline | C14H23N3OS | 131986-45-3 | Details |
| Antibacterial agent 132 | C24H17ClN4OS | 3026790-18-8 | Details |
| Viscidulin I | C15H10O7 | 92519-95-4 | Details |
| TTA-A8 | C22H21F3N4O2 | 1146395-46-1 | Details |
| NSC 617145 | C13H10Cl4N2O4 | 203115-63-3 | Details |
| Simmitecan hydrochloride | C34H39ClN4O6 | 1247847-78-4 | Details |
| CID1231538 | C26H22ClN3O3S2 | 354126-20-8 | Details |
| Estrone sulfate potassium | C18H21KO5S | 1240-04-6 | Details |
| Cucurbit[8]uril | C48H48N32O16 | 259886-51-6 | Details |
| Ximoprofen | C15H19NO3 | 56187-89-4 | Details |
| DSPE-PEG(2000)-amine (sodium salt) | Details |
| NLX-204 hydrochloride(2170405-10-2 free base) | Details |
| Allyl Methyl Sulfide | C4H8S | 10152-76-8 | Details |
| [Lys8, Lys9]-Neurotensin (8-13) acetate | Details |
| IL-20 Protein, Mouse, Recombinant (His) | Details |
| SAE1 Protein, Human, Recombinant | Details |
| PF-04620110 | C21H24N4O4 | 1109276-89-2 | Details |
| Rolapitant hydrochloride | C25H27ClF6N2O2 | 858102-79-1 | Details |
| SI-113 | C23H24N6O | 1392816-46-4 | Details |
| CP 424174 | C22H29ClN2O4S | 210825-31-3 | Details |
| 3-pyridine toxoflavin | C12H10N6O2 | 32502-20-8 | Details |
| Icopezil | C23H25N3O2 | 145508-78-7 | Details |
| AIMP2-DX2-IN-1 | C23H21NO3 | 848256-17-7 | Details |
| JC2-11 | C17H15FO4 | 937820-89-8 | Details |
| Rhizoferrin TFA | Details |
| 8-Hydroxy-2'-deoxyguanosine | C10H13N5O5 | 88847-89-6 | Details |
| Ac-muramic acid | C11H19NO8 | 10597-89-4 | Details |
| Glycolithocholic acid, sodium salt | C26H42NNaO4 | 24404-83-9 | Details |
| ethyl 2,5-Dihydroxybenzoate | C9H10O4 | 3943-91-7 | Details |
| PD-168077 maleate | C24H26N4O5 | 630117-19-0 | Details |
| YM-58790 | C27H31N3O2 | 168830-70-4 | Details |
| Trifluoromethyl-tubercidin | C12H13F3N4O4 | 1854086-05-7 | Details |
| Pyoluteorin | C11H7Cl2NO3 | 25683-07-2 | Details |
| Influenza A H1N1 (A/New Caledonia/20/1999) Hemagglutinin/HA Protein (His) | Details |
| Influenza A H3N2 (A/Perth/16/2009) Hemagglutinin/HA Protein (His) | Details |
| 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid | C22H34O4 | 887752-13-8 | Details |
| GLP-1R Agonist DMB | C13H15Cl2N3O2S | 281209-71-0 | Details |
| CAY10704 | C18H20Cl2N2 | 101784-44-5 | Details |
| Biotin-4-aminophenol | C16H21N3O3S | 901770-40-9 | Details |
| JHU37160 | C19H20ClFN4 | 2369979-68-8 | Details |
| PMX 205 acetate(514814-49-4 free base) | Details |
| Isoprothiolane | C12H18O4S2 | 50512-35-1 | Details |
| Cdk5 Substrate acetate | Details |
| Kaempferol 3,4',7-triacetate | C21H16O9 | 143724-69-0 | Details |
| Fmoc-Ile-OH | C21H23NO4 | 71989-23-6 | Details |
| 1-(2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID | C13H13NO5 | 260555-42-8 | Details |
| AP-C5 | C16H13N5 | 2234272-10-5 | Details |
| Cyclo(L-Phe-L-Pro) | C14H16N2O2 | 3705-26-8 | Details |
| Lumiliximab | 357613-86-6 | Details |
| CTPI-2 | C13H9ClN2O6S | 68003-38-3 | Details |
| GRGDSPK acetate | 144027-77-0 | Details |
| HG106 | C15H13ClN4O2 | 928712-10-1 | Details |
| AQC | C14H11N3O4 | 148757-94-2 | Details |
| COG-1410 acetate | Details |
| 1,3,5-tris(pyridin-4-ylethynyl)benzene | C27H15N3 | 168289-78-9 | Details |
| (±)19(20)-EpDPA | C22H32O3 | Details |
| CB2R PAM | C21H24BrFN2O2 | 2244579-87-9 | Details |
| monoMICAAc | Details |
| 1-Hydroxy-2-butanone | C4H8O2 | 5077-67-8 | Details |
| Lysipressin acetate(50-57-7(fb_acetate)) | C48H69N13O14S2 | 83968-49-4 | Details |
| Product Total： Product Page： | ||||
| 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 | ||||